STOCK TITAN
  1. Home
  2. Sec-filings
  3. BTAI
  4. [8-K] – BioXcel Therapeutics, Inc. (BTAI) (CIK 0001720893)

[8-K] – BioXcel Therapeutics, Inc. (BTAI) (CIK 0001720893)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BTAI logo
Bioxcel Therapeutics Inc

NASDAQ:BTAI

BTAI Rankings

#5415 Ranked by Market Cap
N/A Ranked by Dividends

BTAI Latest News

Oct 14, 2025
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
Oct 13, 2025
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation
Sep 18, 2025
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
Sep 10, 2025
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia
Sep 4, 2025
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

BTAI Latest SEC Filings

Oct 1, 2025
[SCHEDULE 13G] BioXcel Therapeutics, Inc. SEC Filing
Sep 15, 2025
[8-K] BioXcel Therapeutics, Inc. Reports Material Event
Sep 16, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Sep 16, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity
Sep 16, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity

BTAI Stock Data

49.90M
19.08M
3.8%
6.23%
25.27%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN